Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Scrip Team

Latest From Scrip Team

Executives On The Move: New Chief Science Officer At Janux, While New Senior Vice President Joins Pfizer

New chief financial officers at Verrica and Medexus Pharmaceuticals.

Appointments BioPharmaceutical

Executives On The Move: New Chief Scientific Officers At Almirall And FibroGen

Chief brand officer joins Moderna, plus new chief medical officer at Monopar Therapeutics.

Appointments BioPharmaceutical

Coronavirus Update: EMA To Update Comirnaty And Spikevax Labels On Cardiac Safety

Comirnaty and Spikevax to get EU label update on cardiac safety, Japanese filing for REGEN-COV, plus vaccine progress for ReiThera and Genexine.

Coronavirus COVID-19 Vaccines

Executives On The Move: New Chief Financial Officer Joins BioNTech, While Moderna Picks Up New Chief Medical Officer

Merck Gets New Chief Strategy Officer, New Chief Operating And Production Officer At CureVac.

Appointments Leadership

Executives On The Move: New CEOs For Lengo, Draupnir And OncoSec

Leadership moves are also reported at CureVac, while Esperion Therapeutics and Palatin Technologies get new chief medical officers.

Appointments BioPharmaceutical

Coronavirus Update: Once Written Off, Roche's Actemra Finally Gets EUA In COVID-19

Actemra finally gains an emergency use authorization, Lilly's antibodies withdrawn again amid Delta variant concerns, plus Latin America’s belief in an anti-parasite drug in COVID-19 could soon be punctured.

Coronavirus COVID-19 Commercial
See All